SEC 13F Intelligence

Birchview Capital, LP / OCUL

Birchview Capital, LP’s Ocular Therapeutix Inc Position

Does Birchview Capital, LP own Ocular Therapeutix Inc (OCUL)? Yes320.0K shares worth $3M (+1.54% of its 13F portfolio) as of Q1 2026.

Position Value
$3M
Q1 2026
Shares
320.0K
% of Portfolio
+1.54%
Quarters Held
1
currently held

Position History OCUL

Reported value by quarter
Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026320.0K$3M+1.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of OCUL.